Exfoliated dermatitis and hepatitis to first line anti-tubercular therapy with treatment of drug-sensitive tuberculosis with second line anti-tubercular therapy: a roller coaster ride. Chest Disease Reports, v. 12, n. 1, 3 Jun.2024.